Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline

Abstract

Introduction: This guideline establishes clinical practice recommendations for positive airway pressure (PAP) treatment of obstructive sleep apnea (OSA) in adults and is intended for use in conjunction with other American Academy of Sleep Medicine (AASM) guidelines in the evaluation and treatment of sleepdisordered breathing in adults. Methods: The AASM commissioned a task force of experts in sleep medicine. A systematic review was conducted to identify studies, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) process was used to assess the evidence. The task force developed recommendations and assigned strengths based on the quality of evidence, the balance of clinically significant benefits and harms, patient values and preferences, and resource use. In addition, the task force adopted recommendations from prior guidelines as "good practice statements" that establish the basis for appropriate and effective treatment of OSA. The AASM Board of Directors approved the final recommendations. Good Practice Statements: The following good practice statements are based on expert consensus, and their implementation is necessary for appropriate and effective management of patients with OSA treated with positive airway pressure:1. Treatment of OSA with PAP therapy should be based on a diagnosis of OSA established using objective sleep apnea testing.2. Adequate follow-up, including troubleshooting and monitoring of objective efficacy and usage data to ensure adequate treatment and adherence, should occur following PAP therapy initiation and during treatment of OSA. Recommendations: The following recommendations are intended as a guide for clinicians using PAP to treat OSA in adults. A STRONG (ie, "We recommend…") recommendation is one that clinicians should follow under most circumstances. A CONDITIONAL recommendation (ie, "We suggest…") reflects a lower degree of certainty regarding the outcome and appropriateness of the patient-care strategy for all patients. The ultimate judgment regarding any specific care must be made by the treating clinician and the patient, taking into consideration the individual circumstances of the patient, available treatment options, and resources.1. We recommend that clinicians use PAP, compared to no therapy, to treat OSA in adults with excessive sleepiness. (STRONG) 2. We suggest that clinicians use PAP, compared to no therapy, to treat OSA in adults with impaired sleep-related quality of life. (CONDITIONAL) 3. We suggest that clinicians use PAP, compared to no therapy, to treat OSA in adults with comorbid hypertension. (CONDITIONAL) 4. We recommend that PAP therapy be initiated using either APAP at home or in-laboratory PAP titration in adults with OSA and no significant comorbidities. (STRONG) 5. We recommend that clinicians use either CPAP or APAP for ongoing treatment of OSA in adults. (STRONG) 6. We suggest that clinicians use CPAP or APAP over BPAP in the routine treatment of OSA in adults. (CONDITIONAL) 7. We recommend that educational interventions be...

Partial failure of CPAP treatment for sleep apnoea: Analysis of the French national sleep database

“…CPAP tracking systems are routinely used to describe CPAP adherence and monitor leaks and residual events. CPAP telemonitoring is now mandatory in some countries (such as France) in order to obtain the higher level reimbursement rates and recently appeared in the latest American Academy of Sleep Medicine recommendations for CPAP treatment (recommendation 9) . Residual AHI > 5 events/h has been reported in a recent big data analysis as affecting CPAP adherence, and patients with a treatment‐emergent CSA (>5 events/h) were demonstrated as being at higher risk of terminating CPAP therapy.…”

Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy

“…There is increasing evidence that those with moderate to severe sleep apnea, as defined by an Apnea‐Hypopnea Index (AHI) value >15 events per hour of sleep, more often experience sequelae of sleep apnea, including daytime sleepiness and cardiovascular morbidity and mortality . The gold standard for treatment of OSA is considered to be continuous positive airway pressure (CPAP) . However, approximately one‐third of patients have such difficulty with its chronic use that they seek other options or choose to remain untreated.…”

Assessment of obstructive sleep apnoea in primary care: Screening and evaluation strategies

“…The initiation of PAP therapy requires selection of a mode of PAP, device settings and a patient‐device interface. There are two major PAP modalities used, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BPAP), each of these requiring fixed or auto‐titrating technology . CPAP is generally preferred for most patients because it has been well studied, is simpler to use and is less costly.…”